论文部分内容阅读
目的:探讨肿瘤介入化疗与栓塞的合理应用。方法:选取60例晚期肾癌患者为研究对象,随机分组就单纯手术治疗(对照组)与术前合理应用介入化疗与栓塞治疗(观察组)临床效果进行对比。结果:观察组术中平均出血量、输血量均少于对照组,平均手术时间明显短于对照组,差异均有统计学意义(P<0.05)。进行平均3年的随访,观察组生存率为73.3%,显著高于对照组36.7%,差异有显著统计学意义(P<0.05)。结论:合理应用肿瘤介入化疗与栓塞,可显著延长患者生命期限,降低不良事件发生率,改善预后,提高生存质量,具有非常积极的临床意义。
Objective: To explore the reasonable application of tumor intervention chemotherapy and embolization. Methods: Sixty patients with advanced renal cell carcinoma were enrolled in this study. The clinical effects of simple surgery (control group) and preoperative rational use of interventional chemotherapy and embolization (observation group) were compared. Results: The mean blood loss and blood transfusion in the observation group were all less than those in the control group. The average operation time was significantly shorter than that in the control group (P <0.05). After a mean follow-up of 3 years, the survival rate of the observation group was 73.3%, which was significantly higher than that of the control group (36.7%), the difference was statistically significant (P <0.05). Conclusion: The rational application of tumor intervention chemotherapy and embolization can significantly prolong the life of patients, reduce the incidence of adverse events, improve prognosis and improve the quality of life, has a very positive clinical significance.